Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Ichthyosis
NCT07783165 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-08-24
Summary
28 Day Survey study in patients with Ichthyosis
Conditions
- Ichthyosis
Interventions
- DEVICE
-
Doublebase Once
Single daily use Emollient
Sponsors & Collaborators
-
Dermal Laboratories Ltd
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-07
- Primary Completion
- 2026-10-15
- Completion
- 2026-10-15
More Related Trials
-
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis
NCT06248814 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis
NCT03568162 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of DNK333 in Atopic Dermatitis Patients
NCT01033097 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
NCT01756898 ·Status: COMPLETED ·Phase: PHASE2
-
Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis
NCT02369432 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NCT06756438 ·Status: RECRUITING ·Phase: NA
-
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
NCT06397911 ·Status: RECRUITING ·Phase: PHASE2
-
Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis
NCT01678092 ·Status: COMPLETED ·Phase: PHASE1
-
TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis
NCT06733519 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants
NCT07549750 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
NCT07049575 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)
NCT01228513 ·Status: COMPLETED ·Phase: PHASE2
-
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
NCT07011706 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
NCT06073132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Immunopharmacological Effects of Rituximab in Atopic Dermatitis
NCT00267826 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
NCT04021862 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis
NCT00757042 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants
NCT06934980 ·Status: COMPLETED
-
Investigation of Topical SB705498 on Healthy Volunteers
NCT01673529 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis
NCT07175233 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study Evaluating TRIV-573 in Atopic Dermatitis
NCT07782333 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis
NCT04313400 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream
NCT02411162 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07599813 ·Status: RECRUITING ·Phase: PHASE2